Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Accepted on 30 Apr 2025

Assessing the landscape of digital health implementation for data services: The Perspective of Digital Health Experts in Cameroon

in Drugs Outcomes Research and Policies

Frankline Sanyuy Nsai
Palle John Ngunde
Anna Longdoh Njunda
Tendongfor Nicholas
Cho Sabastine Anye
Juliet Nabyonga-Orem
Omer Njajou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1490778

271 views

Brief Research Report

Published on 30 Apr 2025

Regulatory challenges of digital health: the case of mental health applications and personal data in South Africa

in Drugs Outcomes Research and Policies

Marietjie Botes

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1498600

1,250 views

Original Research

Published on 29 Apr 2025

Trajectories of potentially inappropriate medication use among older adults in Saudi Arabia

in Drugs Outcomes Research and Policies

Fouad F. Jabri
Yajun Liang
Kristina Johnell
Jette Möller

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1568160

552 views

Original Research

Published on 28 Apr 2025

A multinational cross-sectional study on knowledge, attitudes, and practices towards magnesium supplements

in Drugs Outcomes Research and Policies

Rana Abutaima
Muna Barakat
Samar Thiab
Hana M. Sawan
Malak Amer
Reem Alzayer
Doaa H. Abdelaziz
Noha O. Mansour
Fatima Saleh
Wael Abu Dayyih

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1550695

1,430 views

Original Research

Published on 28 Apr 2025

Prevalence, risk characteristics, and prediction of low-dose edoxaban treatment in hospitalized patients: a multicenter, observational cohort study

in Drugs Outcomes Research and Policies

Shujuan Zhao
Hengfen Dai
Jiaxin Chen
Ming Ni
Wenxing Peng
Xiaoyu Li
Fen Li
Boya Chen
Haixia Cai
Yinping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1427634

1,046 views

Original Research

Published on 25 Apr 2025

Characteristics, clinical evidence and implementation effects of conditional approvals for drugs in China, a pooled analysis from 2020 to 2023

in Drugs Outcomes Research and Policies

Li Yang
Shuoxin Fan
Jie Zhang
Geyun Huang
Yaoyang Tang
Lijia Xue

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1501525

790 views

Original Research

Published on 24 Apr 2025

Effective inhaler technique education is achievable - assessment and comparison of five inhaler devices errors

in Drugs Outcomes Research and Policies

Monika Marko
Magdalena Klimczak
Marharyta Sobczak
Maciej Wojakiewicz
Tomasz Dębowski
Andrzej Emeryk
Rafał Pawliczak

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538283

1,031 views

Policy and Practice Reviews

Published on 17 Apr 2025

Different routes the same destination: a comparative study of antitrust regulation for pharmaceutical industry in the United States and China

in Drugs Outcomes Research and Policies

Jie Weng
Nailiang Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557876

919 views

Original Research

Published on 15 Apr 2025

Statins and long-term risk of revision surgery after total hip arthroplasty in osteoarthritis: a multi-source data linkage study

in Drugs Outcomes Research and Policies

Andrea D'Amuri
Barbara Bordini
Mauro Pagani
Jacopo Ciaffi
Claudio D'Agostino
Alberto Di Martino
Cesare Faldini
Francesco Ursini

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1492200

726 views

Original Research

Published on 14 Apr 2025

Off-label drug use in China after the Physician Law (2021): legal challenges and solutions

in Drugs Outcomes Research and Policies

Shenbao Liang
Fanxian Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547418

728 views

Original Research

Published on 14 Apr 2025

Optimization and impact of an evidence-based pre-audit prescription decision system in primary healthcare settings

in Drugs Outcomes Research and Policies

Xiao-Hui Yue
Lei Yang
Jing-Jing Zhong
Hong-Mei Liu
Dan Wang
Xue Tao
Gao-Feng Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1491810

847 views

Original Research

Published on 11 Apr 2025

From clinical trials to informing clinical decision-making: a review of patient-reported outcomes in nononcology medicines approved by the European Medicines Agency (2018–2022)

in Drugs Outcomes Research and Policies

Sarah Sauchelli
Courtney Levy
Ari Gnanasakthy
Vaidehi Dave
Lynda Doward
Kristina A. Fitzgerald
Robyn Carson

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536401

1,765 views

Clinical Trial

Published on 11 Apr 2025

Efficacy and safety of intermittent intravenous doxercalciferol in the treatment of secondary hyperparathyroidism in Chinese patients on maintenance hemodialysis: a phase II, open-label, prospective, multicenter study

in Drugs Outcomes Research and Policies

Guang Yang
Yaoyu Huang
Yifei Ge
Xiangbao Yu
Li Liu
Li Xiang
Bin Liu
Chaoqing Gao
Changhua Liu
Yong Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1574679

780 views

Original Research

Published on 10 Apr 2025

Impact of clinical pharmacist interventions on medication administration via enteral feeding tubes in a neurology ward: a pre- and post-educational prospective study

in Drugs Outcomes Research and Policies

Yunus Emre Ayhan
Ömer Faruk Özkanlı
Şeyma Gözelizmir
Anmar Al-Taie
Mesut Sancar
Ipek Midi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519835

878 views

Perspective

Published on 09 Apr 2025

Exploring the complexities of disproportionality analysis in pharmacovigilance: reflections on the READUS-PV guideline and a call to action

in Drugs Outcomes Research and Policies

Tarek A. Hammad
Melissa Naylor
Dona M. Ely
Simon Davies

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573353

1,380 views

Original Research

Published on 08 Apr 2025

Potential inappropriate medications and drug–drug interactions in adverse drug reactions in the elderly: a retrospective study in a pharmacovigilance database

in Drugs Outcomes Research and Policies

Huaqiao Jiang
Yanhua Lin
Weifang Ren
Lina Lu
Xiaofang Tan
Xiaoqun Lv
Ning Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546012

1,914 views